Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD.
Fabian A GreweNoriane Andrina SieviMatteo BradicichMaurice RoederThomas BrackMartin H BrutscheMartin FreySarosh IraniJoerg Daniel LeuppiRobert ThurnheerChristian F ClarenbachMalcolm KohlerPublished in: International journal of chronic obstructive pulmonary disease (2020)
The compliance of COPD-pharmacotherapy with GOLD-guidelines is suboptimal, especially in lower risk groups. The high rates of missed out treatment-adjustments suggest that the familiarity of physicians with guidelines leaves room for improvement.